跳至主要内容
临床试验/ITMCTR2024000084
ITMCTR2024000084尚未招募Unknown

Development and Promotion of Intelligent Diagnostic Equipment for Aplastic Anaemia Based on Traditional Chinese Medicine Digital Four Diagnostics and Deep Learning of Chinese Medicine Evidence

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 至 80(—)
性别
All

入选标准

  • 1) Meet the diagnostic criteria for aplastic anaemia;
  • 2) The patient's age range is 16 to 80 years old;
  • 3) No standard regimen has been used for treatment after the first diagnosis, or the current regimen has been maintained for more than 3 months;
  • 4) Sound liver and kidney function (creatinine ?1.5*ULN, BUN ?1.5*ULN, ALT ?2*ULN, AST ?2*ULN, total bilirubin ?1.5*ULN);
  • 5) Able to comply with the study visit schedule and understand and comply with all trial protocol requirements;
  • 6) Able to understand and voluntarily sign the written informed consent.

排除标准

  • 1) Combination of PNH clones;
  • 2) Allergy to herbal medicinal tablets;
  • 3) Severe cardiac disease, including New York Heart Association (NYHA) class III or IV congestive heart failure, uncontrolled hypertension or hypotension, or severe valvular or endocardial disease resulting in a risk of thromboembolism in the subject;
  • 4) Clinically significant or uncontrolled persistent inflammatory/autoimmune disease (e.g., rheumatoid arthritis, Crohn's disease, ulcerative colitis, celiac disease, systemic lupus erythematosus, etc.);
  • 5) Anticipated haematopoietic stem cell transplantation within 3 months.

研究者

发起方
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)

相似试验